These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6832570

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R, Campbell C, Wellinghoff W, Gelb L.
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pilot study of ribavirin and interferon-beta for chronic hepatitis B.
    Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y.
    Hepatology; 1993 Aug; 18(2):258-63. PubMed ID: 8340055
    [Abstract] [Full Text] [Related]

  • 9. A pilot study of long-term weekly interferon-beta administration for chronic hepatitis B.
    Kagawa T, Morizane T, Saito H, Tsunematsu S, Tada S, Kumagai N, Tsuchimoto K, Sugiura H, Mukai M, Tsuchiya M.
    Am J Gastroenterol; 1993 Feb; 88(2):212-6. PubMed ID: 8424423
    [Abstract] [Full Text] [Related]

  • 10. Persistence of serum hepatitis B virus deoxyribonucleic acid in hepatitis B surface antigen-positive patients with chronic persistent hepatitis treated with prednisone.
    Tong MJ, Liu S, Co RL.
    Gastroenterology; 1987 Apr; 92(4):862-6. PubMed ID: 3556993
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
    Hayashi J, Kashiwagi S, Noguchi A, Ikematsu H, Tsuda H, Tsuji Y, Motomura M.
    Clin Ther; 1989 Apr; 11(1):161-9. PubMed ID: 2497983
    [Abstract] [Full Text] [Related]

  • 12. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients].
    Deal C, Ajana F, Canva V, Mouton Y, Yazdanpanah Y, Wattré P, Bocket L.
    Ann Biol Clin (Paris); 2002 Mar; 60(5):581-8. PubMed ID: 12368144
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 17. Long-term therapy of chronic hepatitis B with lamivudine.
    Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schmid P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle JH.
    Hepatology; 2000 Oct 10; 32(4 Pt 1):828-34. PubMed ID: 11003630
    [Abstract] [Full Text] [Related]

  • 18. A pilot study of steroid withdrawal followed by oral acyclovir in the treatment of chronic type B hepatitis.
    Minuk GY, German GB, Bernstein C, Benarroch A, Gauthier T, Sekla L.
    Clin Invest Med; 1992 Dec 10; 15(6):506-12. PubMed ID: 1286532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.